Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas

Anticancer Research

Volumn 30, Issue 9, 2010, Pages 3445-3449

  Rhiem, Kerstin ^a   Todt, Unda ^a   Wappenschmidt, Barbara ^a   Klein, Annette ^a   Wardelmann, Eva ^b   Schmutzler, Rita Katharina ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

BRCA1 gene; Familial breast cancer; Genotype phenotype correlation; LOH; Loss of heterozygosity

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CAVEOLIN 1; ESTROGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; UVOMORULIN; ATM PROTEIN, HUMAN; CADHERIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; DNA REPAIR; FAMILIAL CANCER; GENE DELETION; GENOTYPE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SOMATIC CELL GENETICS; BREAST TUMOR; CANCER STAGING; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; BREAST NEOPLASMS; CADHERINS; CAVEOLIN 1; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, BRCA1; GENES, BRCA2; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM STAGING; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 77958606449     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689, 1998.
2. Szabo CI and King MC: Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60: 1013-1020, 1997.
3. Cropp C, Nevanlinna H, Pyrhonen S, Ulf-Hakan S, Salminkangan P, Albertsen H, White R and Callahan R: Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res 54: 2548-2551, 1994. (Pubitemid 24173734)
4. Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquemier J, Longy M, Sobol H, Birnbaum D: Loss of heterozygosity in human breast carcinoma in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14: 339-347, 1997.
5. Johnson SM, Shaw JA and Walker RA: Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int J Cancer 98: 205-209, 2002.
6. Futreal PA, Liu Y, Shatuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Edditon K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A and Wiseman R: BRCA1 mutations in primary breast and ovarian carinomas. Science 266: 120-122, 1994.
7. Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, Andrulis IL, Lu J and Ho FC: Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene 18: 4643-4646, 1999.
8. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt TJ: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressen. Nat Genet 9: 444-450, 1995.
9. Sourvinos G and Spandidos DA: Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem Biophys Res Commun 245: 75-80, 1998. (Pubitemid 28414249)
10. Welcsh PL and King MC: BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Gen 10: 705-713, 2001.
11. Staff S, Isola J and Tanner M: Haplo-insufficiency of BRCA1 in sporadic breast cancer. Cancer Res 63: 4978-4983, 2003.
12. Dobovric A and Simpfendörfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57: 3347-3350, 1997. (Pubitemid 27355472)
13. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Herkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB and Herman JG: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92: 564-569, 2000.
14. Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, Trudel M and Akslen LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95: 1482-1485, 2003.
15. Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MR, Giles GG, Hopper JL and Venter DJ: Distinct molecular pathogeneses of early-onset breast cancers in BRCA1/BRCA2 mutation carriers: a population-based study. Cancer Res 59: 2011-2017, 1999.
16. Lakhani SR, van de Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L and Easton DF: The pathology of familial breast cancer: predictive value of immunostochemical markers estrogen receptor, progesterone receptor, HER-2 and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20: 2310-2318, 2002. (Pubitemid 34441658)
17. Hanby AM, Kelsell DP, Potts HW, Gillett CE, Bishop DT, Spurr NK and Barnes DM: Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer. Int J Cancer 88: 204-208, 2000.
18. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livinston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ and Slamon DJ: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21: 236-240, 1999.
19. Spiessl B, Beahrs OB and Hermanek P: UICC TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. Berlin, Springer, 1990.
20. Tavassoli FA and Devilee P: Pathology and Genetics, Tumours of the Breast and Female Genital Organs, IARC WHO Classification of Tumours, No 4, 2003.
21. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377, 1957.
22. Remmele W and Stegner HE: Vorschlag zur einheitlichen Definition eines Immunreaktives Scores (IRS) für den immunhistochemischen Östrogenrezeptornachweis (ERICA) in Mammakarzinomgewebe. Pathologe 8: 138-140, 1987.
23. Schmutzler RK, Bierhoff E, Werkhausen T, Fimmers R, Speiser R, Kubista E, Krebs D, Zeillinger R, Wiestier OD and von Deimling A: Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma. Int J Cancer 74: 322-325, 1997.
24. Sengupta S and Harris CC: P53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6: 44-55, 2005.
25. Gudmundsdottir K and Ashworth A: The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25: 5864-5874, 2006. (Pubitemid 44453442)
26. Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP and Yin Y: Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128: 157-170, 2007.
27. Osorio A, de la Hoya M, Rodriguez-Lopez R, Martines-Ramires A, Cazorla A, Granizo JJ, Esteller M, Rivas C, Caldés T and Benitez J: Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 99: 305-309, 2002.
28. Staff S, Isola JJ, Johannsson O, Borg A and Tanner MM: Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germline mutation carriers and vice versa. Br J Cancer 85: 1201-1205, 2001.
29. Niederacher D, Picard F, van Roeyen C, An HX, Bender HG and Beckmann MW: Patterns of allelic loss on chromosome 17 in sporadic breast carcinoma detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer 18: 181-192, 1997.
30. Rio PG, Pernin D, Bay JO, Albuisson E, Kwiatkowski F, De Latour M, Bernard-Gallon DJ and Bignon YJ: Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int J Oncol 13: 849-853, 1998.
31. Sorlie T, Andersen TI, Bukholm I and Borresen-Dale AL: Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases. Breast Cancer Res Treat 48: 259-264, 1998.
32. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G and Nakamura Y: Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184-7189, 1990.
33. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo Ma, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C et al: Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res 58: 1004-1012, 1998.
34. Luo L, Chen J, Du Q, Dumanski J, Blennow E, Kockum I, Luthman H and Lindblom A: A region close to TP53 shows LOH in familial breast cancer. Int J Mol Med 9: 405-409, 2002.
35. Greenblatt MS, Chappuis PO, Bond JP, Hamel N and Foulkes WD: TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res 61: 4092-4097, 2001.
36. Querzoli P, Albonico G, di Iasio MG, Ferretti S, Rinaldi R, Cariello An Pediali M, Matteuzzi M, Maestri I and Neci I: Biophenotypes and survival of BRCA1- and TP53-deleted breast cancer in young women. Breast Cancer Res Treat 66: 135-142, 2001.
37. Nagahata T, Hirano A, Utada Y, Tsuchiya S, Takahashi K, Tada T, Makita M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y and Emi M: Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers. Breast Cancer 9: 208-215, 2002.
38. Ansquer Y, Gautier C, Fourquet A, Asselain B and Stoppa-Lyonnet D: Survival in early-onset BRCA1 breast cancer patients. Institut Curie Breast Cancer Group. Lancet 352: 541, 1998.